Edition:
United Kingdom

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

518.60INR
10:16am GMT
Change (% chg)

Rs0.60 (+0.12%)
Prev Close
Rs518.00
Open
Rs515.00
Day's High
Rs535.95
Day's Low
Rs513.00
Volume
73,518
Avg. Vol
61,291
52-wk High
Rs648.00
52-wk Low
Rs469.85

Select another date:

Tue, Nov 7 2017

BRIEF-India's Alembic Pharma Sept-qtr consol PAT rises

* Says U.S. formulations business continues to face price erosion on some key products; India branded business showing signs of recovery‍​‍​

BRIEF-Alembic Pharma buys generic drug developer Orit Laboratories

* Says ‍co buys U.S. based generic drug developer Orit Laboratories LLC​ Source text: http://bit.ly/2z3AKCI Further company coverage:

BRIEF-Alembic Pharmaceuticals gets EU GMP certificate for audit conducted at Panelav

* Alembic Pharmaceuticals - gets EU GMP certificate for audit conducted at its formulation facility at Panelav from 8th to 10th Aug Source text for Eikon: Further company coverage:

BRIEF-Alembic Pharma Ltd says sold Baddi plant to Scott Edil Pharmacia Ltd

* Says sold Baddi, Solan plant to Scott Edil Pharmacia Ltd on slump sale basis

BRIEF-Alembic Pharmaceuticals sells formulations manufacturing facility at Baddi to Scott Edil Pharmacia

* Alembic pharmaceuticals says sold on slump sale basis its formulations manufacturing facility at Baddi, dist. Solan to Scott Edil Pharmacia Limited Source text for Eikon: Further company coverage:

BRIEF-India's Alembic Pharmaceuticals says fire at Algerian JV plant

* Says there was a fire incident at Algerian joint venture plant at Constantine, Algeria Constantine, Algeria

BRIEF-Alembic Pharmaceuticals gets U.S. FDA approval for Doxycycline Capsules USP, 75 mg & 100 mg

* Says Alembic Pharmaceuticals Limited receives USFDA approval for Doxycycline Capsules USP, 75 mg and 100 Mg.

BRIEF-India's Alembic Pharma June-qtr consol PAT falls

* June quarter consol profit after tax 633.8 million rupees versus 1.04 billion rupees year ago

BRIEF-India's Alembic Pharma gets FDA nod for generic hypertension drug

* Says ‍received U.S. food & drug administration (USFDA) approval for olmesartan medoxomil and amlodipine tablets​ Source text for Eikon: Further company coverage:

BRIEF-Alembic Pharmaceuticals gets U.S. FDA tentative approval for Dabigatran Etexilate Capsules

* Says alembic pharmaceuticals receives USFDA tentative approval for Dabigatran Etexilate Capsules, 150 mg.

Select another date: